294 related articles for article (PubMed ID: 33611566)
1. Adult Diffuse Astrocytic and Oligodendroglial Tumors.
Gestrich CK; Couce ME; Cohen ML
Neurosurgery; 2021 Oct; 89(5):737-749. PubMed ID: 33611566
[TBL] [Abstract][Full Text] [Related]
2. Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors.
Malzkorn B; Reifenberger G
Pathologe; 2019 Jun; 40(Suppl 1):9-17. PubMed ID: 31025086
[TBL] [Abstract][Full Text] [Related]
3. [World Health Organization Classification of Central Nervous System Tumours, 5
Ichimura K
No Shinkei Geka; 2023 Mar; 51(2):349-363. PubMed ID: 37055056
[TBL] [Abstract][Full Text] [Related]
4. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.
Weller M; van den Bent M; Preusser M; Le Rhun E; Tonn JC; Minniti G; Bendszus M; Balana C; Chinot O; Dirven L; French P; Hegi ME; Jakola AS; Platten M; Roth P; Rudà R; Short S; Smits M; Taphoorn MJB; von Deimling A; Westphal M; Soffietti R; Reifenberger G; Wick W
Nat Rev Clin Oncol; 2021 Mar; 18(3):170-186. PubMed ID: 33293629
[TBL] [Abstract][Full Text] [Related]
5. cIMPACT-NOW: a practical summary of diagnostic points from Round 1 updates.
Louis DN; Ellison DW; Brat DJ; Aldape K; Capper D; Hawkins C; Paulus W; Perry A; Reifenberger G; Figarella-Branger D; von Deimling A; Wesseling P
Brain Pathol; 2019 Jul; 29(4):469-472. PubMed ID: 31038238
[TBL] [Abstract][Full Text] [Related]
6. [The 2021 WHO classification of tumours of the central nervous system].
Figarella-Branger D; Appay R; Metais A; Tauziède-Espariat A; Colin C; Rousseau A; Varlet P
Ann Pathol; 2022 Oct; 42(5):367-382. PubMed ID: 34865882
[TBL] [Abstract][Full Text] [Related]
7. Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System.
Onizuka H; Masui K; Komori T
Int J Clin Oncol; 2020 Jun; 25(6):997-1003. PubMed ID: 32468200
[TBL] [Abstract][Full Text] [Related]
8. The Essentials of Molecular Testing in CNS Tumors: What to Order and How to Integrate Results.
Feldman AZ; Jennings LJ; Wadhwani NR; Brat DJ; Horbinski CM
Curr Neurol Neurosci Rep; 2020 May; 20(7):23. PubMed ID: 32445025
[TBL] [Abstract][Full Text] [Related]
9. [Molecular Diagnostic Approaches for Diffuse Gliomas Based on Updated WHO Classification and cIMPACT-NOW Proposals].
Masui K; Komori T
No Shinkei Geka; 2021 May; 49(3):510-519. PubMed ID: 34092556
[TBL] [Abstract][Full Text] [Related]
10. Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics.
Petersen JK; Boldt HB; Sørensen MD; Blach S; Dahlrot RH; Hansen S; Burton M; Thomassen M; Kruse T; Poulsen FR; Andreasen L; Hager H; Ulhøi BP; Lukacova S; Reifenberger G; Kristensen BW
Neuropathol Appl Neurobiol; 2021 Feb; 47(1):108-126. PubMed ID: 32696543
[TBL] [Abstract][Full Text] [Related]
11. Major Changes in 2021 World Health Organization Classification of Central Nervous System Tumors.
Kurokawa R; Kurokawa M; Baba A; Ota Y; Pinarbasi E; Camelo-Piragua S; Capizzano AA; Liao E; Srinivasan A; Moritani T
Radiographics; 2022; 42(5):1474-1493. PubMed ID: 35802502
[TBL] [Abstract][Full Text] [Related]
12. The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 2-Summary of Imaging Findings on Pediatric-Type Diffuse High-Grade Gliomas, Pediatric-Type Diffuse Low-Grade Gliomas, and Circumscribed Astrocytic Gliomas.
Park YW; Vollmuth P; Foltyn-Dumitru M; Sahm F; Ahn SS; Chang JH; Kim SH
J Magn Reson Imaging; 2023 Sep; 58(3):690-708. PubMed ID: 37069764
[TBL] [Abstract][Full Text] [Related]
13. [The 2021 WHO Classification of Tumors, 5th edition, Central Nervous System Tumors: A Short Review].
Komori T
Brain Nerve; 2022 Jun; 74(6):803-809. PubMed ID: 35676215
[TBL] [Abstract][Full Text] [Related]
14. [Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors. German version].
Malzkorn B; Reifenberger G
Pathologe; 2019 Mar; 40(2):131-139. PubMed ID: 30790013
[TBL] [Abstract][Full Text] [Related]
15. The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.
Bale TA; Rosenblum MK
Brain Pathol; 2022 Jul; 32(4):e13060. PubMed ID: 35218102
[TBL] [Abstract][Full Text] [Related]
16. [Update on the 2016 WHO classification of tumors of the central nervous system - Part 1: Diffusely infiltrating gliomas].
Švajdler M; Rychlý B; Zámečník J; Švajdler P
Cesk Patol; 2017; 53(1):12-21. PubMed ID: 28248117
[TBL] [Abstract][Full Text] [Related]
17. Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.
Wood MD; Halfpenny AM; Moore SR
Diagn Pathol; 2019 Apr; 14(1):29. PubMed ID: 30967140
[TBL] [Abstract][Full Text] [Related]
18. Classification and Grading of Central Nervous System Tumors According to the World Health Organization 5th Edition.
Yoda RA; Cimino PJ
Semin Neurol; 2023 Dec; 43(6):833-844. PubMed ID: 37949117
[TBL] [Abstract][Full Text] [Related]
19. Glioblastoma: Changing concepts in the WHO CNS5 classification.
Chen J; Han P; Dahiya S
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S24-S32. PubMed ID: 35562131
[TBL] [Abstract][Full Text] [Related]
20. The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 3-Summary of Imaging Findings on Glioneuronal and Neuronal Tumors.
Park YW; Vollmuth P; Foltyn-Dumitru M; Sahm F; Choi KS; Park JE; Ahn SS; Chang JH; Kim SH
J Magn Reson Imaging; 2023 Dec; 58(6):1680-1702. PubMed ID: 37715567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
